FOXA1 and pancreatic ductal adenocarcinoma: It reported that FOXA1 TF drives enhancer reprogramming during pancreatic ductal adenocarcinoma, thereby triggering an aberrant developmental transition toward embryonic endoderm (Roe et al, 2017).